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Summary 
Background Baker's asthma is an important occupational allergic disease. Wheat lipid transfer 
protein (LTP) Tri a 14 is a major allergen associated with wheat allergy. No panel of wheat 
recombinant allergens for component-resolved diagnosis of baker's asthma is currently 
available. 
Objective To evaluate the potential role of recombinant Tri a 14 as a novel tool for the 
diagnosis of baker's asthma, and to test the heat and proteolytic resistance of the wheat LTP 
allergen. 
Methods A cDNA encoding Tri a 14 was isolated and sequenced, the recombinant allergen 
produced in Pichia pastoris and purified by chromatographic methods. Physicochemical and 
immunological comparison of the natural and recombinant forms of Tri a 14 was carried out 
by N-terminal amino acid sequencing, matrix-assisted laser desorption/ionization mass 
spectrometry, circular dichroism (CD) analysis, IgE immunodetection, and specific IgE 
determination and ELISA-inhibition assays using a pool or individual sera from 26 patients 
with baker's asthma. Thermal denaturation and simulated gastrointestinal digestion of both 
Tri a 14 forms were checked by spectroscopic and electrophoretic methods, respectively, and 
biological activity by basophil activation test (BAT). 
Results Natural and recombinant Tri a 14 were similarly folded, as indicated by their nearly 
identical CD spectra and heat denaturation profiles. A high interclass correlation coefficient 
(0.882) was found between specific IgE levels to both Tri a 14 proteins in individual sera from 
baker's asthma patients, but a slightly lower IgE-binding potency of rTri a 14 was detected by 
ELISA-inhibition assays. Natural and recombinant Tri a 14 elicited positive BAT in two and 
one out of three patients, respectively. Heat denaturation profiles and simulated 
gastrointestinal digestion assays indicated that Tri a 14 displayed a high heat and digestive 
proteolytic resistance, comparable to those of peach Pru p 3, the model food allergen of the 
LTP family. 
Conclusions Recombinant Tri a 14 is a potential tool for baker's asthma diagnosis, based on its 
physicochemical and immunological similarity with its natural counterpart. Wheat Tri a 14 
shows a high thermal stability and resistance to gastrointestinal digestion. 
Keywords baker's asthma, lipid transfer protein, molecular diagnosis, proteolytic resistance, 
recombinant allergen, wheat 
Tedades Respiratorias (CIBERES), Madrid, Spain. 
Introduction 
Progress in genetic and protein engineering has allowed 
for the cloning and production of recombinant forms of 
relevant allergenic proteins, as well as the identification of 
their IgE-binding molecular regions (B epitopes) and their 
site-directed mutation to obtain hypoallergenic variants 
[1, 2]. There is growing evidence that the use of panels 
of recombinant allergens, termed component-resolved 
diagnostics [3], instead of crude extracts from the aller-
genic sources, provides a refined molecular analysis of 
sensitization patterns, thus enhancing diagnosis, predic-
tion of cross-sensitizations and strategies of immunother-
apy [1-3]. However, a previous step for the use of 
recombinant allergens in diagnostic panels is to prove 
that their immunological and physicochemical proper-
ties are equivalent to those of their natural counterparts 
[4, 5]. 
Baker's asthma is an important occupational disease, 
mainly caused by an IgE-mediated allergic response to 
inhalation of cereal flours [6]. Specific wheat-IgE sensiti-
zation rates over 10% and prevalence around 10% for 
lower respiratory symptoms and asthma have been re-
cently reported [7]. Several families of salt-soluble pro-
teins from wheat flour [8-12], as well as prolamins 
(storage proteins not extractable by salt solutions) [12, 
13], have been identified as potential allergens associated 
with baker's asthma. However, low (20-30%) specific IgE 
sensitization rates have been found for most of these 
allergen families [10-13], and a large variability of IgE-
binding patterns of wheat protein has been observed 
among individual sera from patients with baker's asthma 
[14]. Thus, it remains uncertainty as to which proteins are 
the major allergens in this allergic disorder [6]. Further-
more, great differences in the concentration of potential 
allergens in commercial wheat diagnostic extracts have 
been reported [15]. Overall, this scenario warrants neces-
sity to improve the diagnostic tools (panel of purified 
allergens) for baker's asthma. 
Several allergens linked to this occupational disease, 
such as peroxidase [9], thioredoxin [10], serine proteinase 
inhibitor [11] and a(3 gliadin [13], have been isolated and 
tested as purified natural or recombinant proteins. How-
ever, their use as molecular markers for component 
resolved diagnosis presents three main constrains: specific 
IgE sensitization rates below 50%, lack of in vivo (i.e. STP) 
data, and a limited number of sera analysed (from 10 to 22 
patients, except in the case of a(3 gliadin). Taking into 
account this situation, wheat non-specific lipid transfer 
protein (LTP) Tri a 14, recently identified as a major 
allergen associated with baker's asthma [16], seems to be 
a good candidate to include in a diagnostic panel. It is 
supported by the sensitization rate (60% of sera with 
specific IgE to the allergen) and in vivo [skin prick test 
(SPT)]-positive responses (in 15 out of 24 subjects; 62%) 
found with purified natural Tri a 14 in a group of 40 
Spanish patients with baker's asthma. Moreover, Tri a 14 
has been also described as a main allergen linked to wheat 
food (ingestion) allergy [17], and causing cross-reactivity 
with relevant food allergens belonging to the LTP panal-
lergen family, as peach Pru p 3 [16, 18]. Interestingly, 
preliminary data point to a lower resistance of Tri a 14 to 
heat treatment than other allergenic LTPs, such as maize 
Zea m 14 [17], and structural differences between Tri a 14 
and LTP allergens from maize and fruits have been 
suggested [19]. 
We reported here the cloning and production of recom-
binant Tri a 14, the equivalent physicochemical and 
immunological properties of its natural and recombinant 
forms, and the resistance of Tri a 14 to heat and gastro-
intestinal digestion. 
Materials and methods 
Patients and sera 
Twenty-six patients with baker's asthma caused by wheat 
flour inhalation were selected at the Servicio de Alergia, 
Hospital La Paz (Madrid, Spain; numbers 1-10 in Table 1) 
and Fundacion Jimenez Diaz (Madrid, Spain; numbers 
11-26 in Table 1). All selected patients had: (1) a convin-
cing clinical history of occupational asthma provoked by 
inhalation of wheat flour in the workplace; (2) an SPT-
positive response to a homemade wheat extract [16]; (3) a 
specific IgE level to wheat >0.35kU/L (mean 12.9kU/L; 
range 0.4-74.6 kU/L), as measured by the Phadia CAP 
System FEIA (Phadia, Uppsala, Sweden); and (4) a positive 
specific inhalation challenge test to wheat flour, using a 
method previously described [20]. Demographic and clin-
ical data of selected patients are summarized in Table 1. 
Written informed consent was obtained from all patients, 
and the study was approved by the ethics committees of 
Hospital La Paz and Fundacion Jimenez Diaz (Madrid, 
Spain). 
A pool of sera from all 26 selected patients was used for 
IgE immunodetection and ELISA-inhibition assays, and 
individual sera were tested in specific IgE determination 
assays to natural and recombinant Tri a 14 and to 
recombinant peach Pru p 3. 
Isolation of the cDNA encoding Tri a 14 and expression of 
the recombinant allergen in Pichia pastoris 
Total RNA from wheat bran was obtained by the method 
of Chang et al. [21]. The reverse transcription was carried 
out with 2(ig of total RNA using the oligonucleotide 
primer 5'-GATGGATGAGCTGAGCACCAGCTTG-3' and 
the High Capacity cDNA Reverse Transcription Kit (Ap-
plied Biosystems, Foster City, CA, USA). The cDNA 
obtained was amplified by polymerase chain reaction 
Table 1. Demographic data and specific IgE levels to wheat and purified natural (n) and recombinant (r) Tri a 14 and peach rPru p 3 of the selected 
patients with baker's asthma 
Patient no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
Age (years)/sex 
34/M 
48/M 
50/M 
48/M 
49/M 
35/M 
41/M 
43/M 
44/F 
53/F 
35/M 
29/M 
36/M 
39/M 
28/M 
27/M 
26/M 
54/M 
42/F 
54/M 
26/M 
31/M 
43/M 
34/F 
21/F 
35/F 
Specific IgE to 
wheat (CAP, kU/L) 
3.0 
8.2 
4.9 
0.5 
3.1 
8.5 
0.4 
35.8 
6.4 
1.2 
74.2 
18.0 
1.7 
25.8 
2.6 
7.9 
2.4 
2.5 
3.7 
1.7 
74.6 
0.8 
13.8 
2.0 
19.0 
1.9 
Specific IgE to* 
nTri a 14 
0.17 (neg.) 
0.16 (neg.) 
0.25 
0.26 
0.24 
0.67 
0.18 (neg.) 
0.32 
0.16 (neg.) 
0.32 
0.19 (neg.) 
0.58 
0.32 
0.30 
0.26 
0.14 (neg.) 
0.26 
0.12 (neg.) 
0.22 
0.11 (neg.) 
0.34 
0.25 
0.12 (neg.) 
0.24 
0.25 
0.12 (neg.) 
(ELISA, 0D unit) 
rTri a 14 
0.20 (neg.) 
0.31 
0.29 
0.26 
0.26 
0.70 
0.15 (neg.) 
0.34 
0.14 (neg.) 
0.23 
0.25 
0.83 
0.37 
0.33 
0.13 (neg.) 
0.16 (neg.) 
0.25 
0.15 (neg.) 
0.18 (neg.) 
0.11 (neg.) 
0.35 
0.21 (neg.) 
0.12 (neg.) 
0.25 
0.15 (neg.) 
0.15 (neg.) 
r P r u p 3 
0.05 (neg.) 
0.05 (neg.) 
0.05 (neg.) 
0.09 (neg.) 
0.25 
0.04 (neg.) 
0.06 (neg.) 
0.04 (neg.) 
0.03 (neg.) 
0.26 
0.07 (neg.) 
0.32 
0.04 (neg.) 
0.26 
0.03 (neg.) 
0.09 (neg.) 
0.26 
0.04 (neg.) 
0.26 
0.25 
0.28 
0.24 
0.05 (neg.) 
0.16 (neg.) 
0.07 (neg.) 
0.13 (neg.) 
Values are means (n = 3). 0D<0.21 units (mean [OD units, n= 12] ±3SD to BSAused as negative control: 0.081 +3 xO.043 = 0.21). 
neg, negative value. 
(PCR) using the oligonucleotide 5' primer: 5'-TACGGT 
GCACTGCACTGTTAGCTACAGACC-3' and 3' primer: 5'-
GATGGATGAGCTGAGCACCAGCTTG-3', designed from 
LTP cDNAs previously reported [22]. The amplification 
was carried out with Taq-Gold DNA polymerase (Perkin-
Elmer, Branchburg, NY, USA) as recommended by the 
manufacturer. The PCR program was 5 min denaturation 
at 94 °C, followed by 30 cycles each of 30 s denaturation at 
94 °C, 1 min annealing at 68 °C, and 2 min at 72 °C, and 
final extension for 7 min at 72 °C. The PCR products were 
cloned into pGEM T-Easy vector (Promega, Madison, WI, 
USA), and these constructs were used to transform Escher-
ichia coli XL 1-Blue cells. The DNAs from several clones 
were sequenced using the ABI PRISM Dye Terminator kit 
and an ABI 3100 sequencer (Perkin-Elmer Biosystem, 
Warrington, UK). 
The encoding region of the Tri a 14 cDNA was amplified 
by PCR with Taq-Gold DNA polymerase (Perkin-Elmer), a 
sense primer 5'-CCCTCGAGAAAAGAGAGGCTGAAATC 
GACTGCGGCCACG-3' [Xhol restriction site underlined) 
and an antisense S'-CGGAATTCTTACACCCTGCTGCAG 
TCGATG-3' (£coRI restriction site underlined). The sense 
primer allows fusion of the Tri a 14 encoding region in-
frame with the sequence coding for the pre-prosequence 
of the Saccharomyces cerevisiae a factor present in 
plasmid pPIC9. This PCR product was purified, digested 
with Xhol/EcoRl restriction enzymes and inserted into the 
same sites of the pPIC9 vector to transform XL 1-Blue 
E. coli, and the DNA from several clones was sequenced to 
confirm the in-frame arrangement described above. 
Ten micrograms of pPIC9/Tri a 14 were digested with 
BgRl restriction enzyme and the larger purified fragment 
was used to transform GS115 P. pastoris cells by electro-
poration following the Invitrogen manual recommenda-
tions (Invitrogen Corporation, De Schelp, the Netherlands). 
Transformed cells were grown on minimal glucose plates 
at 30 °C during 3-4 days, and screening for positive clones 
was performed by patching the colonies in replica-plating 
on minimal glucose vs. minimal methanol plates. The 
selected transformants were cultured in buffered glycerol 
minimum medium during 48 h at 30 °C. Cells were then 
collected by centrifugation, and expression of the recom-
binant protein was induced by resuspension in buffered 
methanol minimum medium. 
Purification of recombinant and natural Tri a 14 
The supernatants from transformed P. pastoris cultures 
obtained after induction were dialysed against 0 .1M 
ammonium acetate, pH 6.8 and freeze-dried. This pre-
paration was fractionated by gel filtration on a Superdex 
HR 75 16/60 column (Pharmacia Biotech, Uppsala, Swe-
den), eluting with 0.1 M ammonium acetate, pH 6.8 (1 mL/ 
min). Fractions enriched in rTri a 14 were pooled, freeze-
dried and then separated by RP-HPLC on a Nucleosil 300-
C4 column (8x250 mm; particle size 5 urn; Scharlau 
Science, Barcelona, Spain). Elution was performed with a 
gradient of acetonitrile in 0.1% trifluoroacetic acid (10% 
during 5 min, and 10-100% in 150 min; 1 mL/min). Chro-
matographic peaks containing rTri a 14 were identified by 
SDS-PAGE separation followed by immunodetection with 
anti-Pru p 3 rabbit polyclonal antibodies or a serum pool 
from baker's asthma patients. 
Natural Tri a 14 was isolated as previously described 
[16]. 
The isolated nTri a 14 and rTri a 14 were quantified by a 
commercial bicinchoninic acid test (Pierce, Cheshire, UK). 
Purity of both protein preparation was tested by SDS-
PAGE, N-terminal amino acid sequencing with an Applied 
Biosystems Procise 494 gas-phase sequencer, and matrix-
assisted laser desorption/ionization (MALDI) mass spec-
trophotometric analysis with a Biflex III Spectrometer 
(Bruker-Franzen Analytik, Bremen, Germany), using stan-
dard methods. 
Circular dichroism and thermal denaturation spectroscopy 
Circular dichroism (CD) measurements were performed 
on a Jasco Model J-720 Spectropolarimeter (Japan 
Spectroscopic Co., Tokyo, Japan) using a quartz cell with 
a 1 mm light path length, thermostatically controlled with 
a Jasco Model 423S Peltier-type temperature controller, 
and a thermostated cell holder, interfaced with a thermo-
static bath. The far-UV spectra were recorded at 20 °C 
from 190 to 260 nm, as an average of five scans after 
being corrected by sutration of a buffer blank with the 
following parameters: scan speed, 50nm/min; bandwidth, 
1 nm; response time, 4 s; and step resolution, 0.2 nm. 
Thermal denaturation data were recorded in the tempera-
ture range 5-90 °C at 220 nm by the following step scan 
procedure: heating rate, 1 °C/min; response, 4s; recorder 
interval, 0.2 °C. The protein concentration used were 17.3 
UM for natural Pru p 3, 17.7 UM for natural Tri a 14 and 
13.0 UM for recombinant Tri a 14, as quantified by 
using amino acid analysis after acid hydrolysis. All 
proteins were in 65 mM potassium phosphate buffer, pH 
7.2. Optical activity was expressed as mean residue 
ellipticity [9], in degrees cm2/dmol, based on the calcu-
lated mean residue weight of each protein. Analysis 
of protein secondary structure from CD spectra was 
performed using the CDSSTR program included at the 
DICHROWEB site (http://public-l.cryst.bbk.ac.uk/cdweb/ 
html) [23]. 
Immunodetection assays 
Samples (15 (ig of protein from supernatants of induced 
and not induced P. pastoris transformed cultures, and 3 (ig 
of purified nTri a 14 and rTri a 14) were fractionated by 
SDS-PAGE on Bio-Rad Miniprotean III System gels (15% 
polyacrylamide) (Bio-Rad Laboratories, Hercules, CA, 
USA), according to the method of Laemmli [24]. The 
fractionated samples were then electrotransferred onto 
polyvinilidene difluoride membranes. After blocking, 
membranes were incubated overnight with a pool of sera 
from the 26 selected patients with baker's asthma (1 :5 
dilution), washed and incubated with goat anti-human 
IgE-peroxidase conjugate (Biosource, Camarillo, CA, USA) 
(1:3000 dilution; 1 h). Detection of IgE-binding compo-
nents was achieved by means of chemiluminiscence, 
according to the manufacturer's instructions (Amersham 
Biosciences, Little Chalfont, UK). A pool of sera (1:5 
dilution) from bakers non-allergic to wheat (negative IgE 
and SPT responses and non symptoms) was tested as a 
negative control [16]. No band was recognized by this 
control serum pool in any of the samples tested. 
Alternatively, replica gels were immunodetected with 
rabbit polyclonal antibodies to the peach allergen Pru p 3 
(1:500 dilution), and then treated with goat anti-rabbit IgG 
peroxidase-conjugated antibody (1:5000 dilution; Sigma, 
SteinHeim, Germany), and revealed as described above. 
Specific IgE determination and EIISA-inhibition assays 
ELISAs to determine specific IgE to nTri a 14 and rTri a 14 
(5(ig/mL as solid phase) of the 26 individual sera (1 :5 
dilution) from patients with baker's asthma, were per-
formed as previously described [5]. BSA (5(ig/mL) and a 
serum pool from subjects (n= 10) allergic to dust mites, 
but not plant foods or pollens, were used as negative 
controls. Specific IgE levels were considered to be positive 
when >0.21 OD units (see Table 1). All tests were 
performed in triplicate. 
ELISA-inhibition assays were carried out by the same 
method, except that the pool of sera was comprised of 
those individual sera (n = 18) with specific IgE to nTri a 14 
and/or rTri a 14 (see Table 1), and was previously 
incubated with 10, 5, 2 and 1 |ig/mL of the natural or 
recombinant Tri a 14 forms as inhibitor (3 h at 25 °C). All 
tests were performed in triplicate. 
Basophil activation tests 
rTri a 14, nTri a 14 and a wheat salt-soluble protein 
preparation were tested at 0.1-1 |ig/mL for activation of 
basophils from three whole blood samples of baker asth-
matic donors and one atopic non-asthmatic donor based 
on analysis of up-regulation of surface expression of 
CD63 on IgE-positive basophils by flow cytometry [25]. 
The tests were considered positive when the stimulation 
index (% of activated basophils with allergen/% of acti-
vated basophils at baseline conditions) was > 5. 
Simulated gastric and duodenal digestion 
Digestion of purified nTri a 14, rTri a 14 and nPru p 3 by 
simulated gastric fluid (SGF) was performed essentially as 
described by Diaz-Perales et al. [26]. The purified allergens 
(1 ug/uL) were dissolved in SGF solution (100 rriM HC1, pH 
1.2, 30mM NaCl), containing 0.32% (w/v) of pepsin A 
(Calbiochem, Darmstadt, Germany). Digestion was carried 
out at 37 °C during 120 min. Control samples without 
pepsin were included. 
The in vitro duodenal digestion was achieved following 
the method described by Moreno et al. [27]. The freeze-
dried samples resulting after 120 min of gastric digestion 
were dissolved in simulated duodenal solution (0 .125M 
bile salt mix of sodium taurocholate and glycodeoxy-
cholic acid (Calbiochem), 1M CaCl2, 0 .25M Tris, pH 6.5; 
porcine pancreatic lipase (0.1%; Calbiochem); porcine 
colipase (0.055% w/v; Calbiochem); trypsin (0.1% w/v; 
Sigma); and a-chymotrypsin (0.4% w/v; Sigma). The 
digestion was carried out at 37 °C and aliquots were taken 
at 0, 2, 30 and 120 min. The reaction was stopped by 
heating at 80 °C during 5 min, and samples were 
then freeze-dried. Control samples without trysin and 
a-chymotrypsin were included. 
Samples taken at different stages of digestion (5uL) 
were analysed by SDS-PAGE on 12% polyacrylamide 
NuPAGE® Novex Bis-Tris precast gels (Invitrogen, Carls-
bad, CA, USA), and Coomassie R125 stained. 
Statistical analysis 
The Student t-test was used to compare the specific IgE 
levels to nTri a 14 and rTri a 14 in 26 individual sera from 
patients with baker's asthma. Correlation between specific 
IgE levels to the different allergens tested was analysed by 
one-way intraclass correlation coefficient (ICC). The com-
parison and the correlation were performed at a signifi-
cant level of P<0.05. All test were performed using SPSS 
statistical software version 12 for Windows (SPSS Inc., 
Chicago, IL, USA). 
Results 
Production and characterization of recombinant Tria 14 
Natural Tri a 14 was isolated from a wheat bran extract by 
means of a two-step chromatographic procedure pre-
viously described [16]. Purity of the protein was ascer-
tained by a single SDS-PAGE band of the expected 
apparent molecular weight (Fig. la), a single N-terminal 
amino acid sequence (IDXGHVDSLVR), which completely 
matched that reported by Palacin et al. [16], and a major 
sharp peak at 9667 Da in MALDI analysis. 
Based on the determined N-terminal amino acid se-
quence, together with the nucleotide sequences of cDNA 
clones encoding wheat LTPs [22], specific oligonucleotide 
primers were designed to identify the full cDNA corre-
sponding to Tri a 14. Characterization of the selected 
clone rendered a nucleotide sequence (Fig. 2) identical to 
that of the cDNA clone Ta Ltp9.1a [22] (accession no. 
AJ852536), which encodes a LTP isoform highly ex-
pressed in hexaploid (bread) wheat seed. The correspon-
dence of purified natural Tri a 14 and the amino acid 
sequence deduced from the selected cDNA clone (Fig. 2) 
was supported by their identical N-terminal sequence and 
compatible molecular mass (9607 Da calculated from the 
amino acid sequence shown in Fig. 2). 
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Fig. 1. Crude extracts from supernatants of induced (+1) and not induced 
(—1) Pichia pastoris yeast cultures transformed with pPIC9/Tri a 14 
vector, and purified natural (n) and recombinant (r) Tri a 14, were 
separated by SDS-PAGE and stained with Coomassie Blue (a), or 
immunodetected with anti-Pru p 3 rabbit polyclonal antibodies (b) or 
with a serum pool from baker's asthma patients (c). 
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Fig. 2. Nucleotide sequence and deduced amino acid sequence of the selected cDNA clone encoding Tri a 14. 
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Fig. 3. Comparison of circular dichroism spectra of natural (n) and recombinant (r) Tri a 14 (a), and natural Tri a 14 and peach Pru p 3 (b). Samples of 
purified proteins (17.7-13 UM) in 65 mM potassium phosphate buffer, pH 7.2, were analysed at 20 °C. 
To produce the recombinant allergen, P. pastoris GS115 
cells were transformed with pPIC9 expression plasmid 
carrying the Tri a 14 cDNA (pPIC9/Tri a 14) and induced 
with methanol (Fig. 1). The expressed rTri a 14 was then 
purified from supernatants of the transformed yeast 
cultures by gel-filtration chromatography followed by 
reverse-phase HPLC. Proper expression and purification 
were confirmed by the presence of a single band in SDS-
PAGE, its recognition by rabbit polyclonal antibodies to 
Pru p 3, the major LTP allergen from peach fruit, and the 
binding of rTri a 14 to IgE from sera of patients with 
baker's asthma (Fig. 1). Furthermore, the isolated recom-
binant allergen showed a single N-terminal amino acid 
sequence (EAEIDXGHVD) corresponding to that of the 
natural form, but with three (EAE) extra residues at the 
N-terminus by an alternative processing of the signal 
peptide of P. pastoris, and a molecular mass of 9913 Da 
in MALDI analysis, in agreement with that calculated from 
its putative full amino acid sequence (9936Da). 
Natural and recombinant Tri a 14 present equivalent 
secondary structure patterns and heat resistance 
Comparisons of the far-UV spectra at 20 °C of natural and 
recombinant Tri a 14, as well as natural Tri a 14 and peach 
Pru p 3, selected as model of LTP allergens from plant 
foods [18], are presented in Fig. 3. No difference between 
nTri a 14 and rTri a 14 was detected, suggesting that the 
native structure of the recombinant form is essentially the 
same as that of the natural allergen. Similar CD spectra 
were also found for nTri a 14 and nPru p 3. The strong 
structural similarity among the three allergens was further 
confirmed by secondary structure calculations (Table 2). 
Optimal good fittings parameters NRMSD (normalized 
root mean square deviation), issued from the comparison 
between experimental and back-calculated data (SP43 
reference set), were obtained with the CDSSTR program 
[23, 28], reflecting the accurate analysis of secondary 
structure (NRMSD ^ 0.002 in all cases). The secondary 
Table 2. Secondary structure composition of natural Tri a 14 and Pru p 3, 
and recombinant Tri a 14 allergens, as calculated from their far-UV 
CD data 
Allergen 
nTri a 14 
rTri a 14 
nPru p 3 
Secondary 
a-helix 
70 
66 
71 
structure 
P-sheet 
10 
13 
12 
(0/0 
P-turn 
9 
6 
7 
Unordered 
11 
15 
10 
NRMSD 
0.001 
0.002 
0.001 
CD, circular dichroism; NRMSD, normalized root mean square deviation. 
structure found for both Tri a 14 and Pru p 3 is dominated 
by a-helices (^70%), in agreement with the known X-ray 
structures of these allergens [29, 30]. 
The thermal unfolding of nTri a 14, rTri a 14 and nPru p 
3 was monitored by CD, measuring changes in molar 
ellipticity at 220 nm upon heating (up to 90 °C; see Fig. 
4). Similar scans were obtained for the three allergens with 
non-unfolding transition in the range 5-90 °C. Analysis of 
the temperature progress unfolding curves reveals that the 
native conformations of all three proteins were thermally 
stable up to 70 °C, with minimum partial loss of their a-
helical structure. The secondary structure was only par-
tially perturbed upon heating to 90 °C, but even retaining 
most of their native state a-helical content (77%, 82% and 
51% for nTri a 14, rTri a 14 and nPru p 3, respectively). 
Overall, these results indicated that these allergens display 
a high thermal stability. 
Natural and recombinant Tri a 14 show similar 
IgE-binding capacity 
Besides their equivalent structural and heat denaturation 
behaviour, it should be also established that nTri a 14 and 
rTri a 14 exhibited similar IgE-binding capacity. A com-
plementary dual experimental approach led to cover this 
requirement. Specific IgE determination to both allergen 
forms was performed in 26 individual sera from patients 
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Fig. 5. ELISA-inhibition with natural (n) and recombinant (r) Tri a 14 in the solid-phase and as inhibitors. Means [n = 3) and SDs (bars) are represented. 
with baker's asthma (Table 1). Positive assays were ob-
served in 61% (16/26) and 54% (14/26) of sera for nTri a 
14 [mean (OD units)±SD: 0.25±0.13] and rTri a 14 [mean 
(OD units)±SD: 0.26±0.17], respectively. A strong corre-
lation was found between the levels of specific IgE to both 
recombinant and natural Tri a 14 (ICC = 0.882; P<0.001). 
By contrast, only 34% (9/26) of sera showed specific IgE to 
peach rPru p 3 (Table 1), and no correlation was detected 
between the IgE levels to this allergen and those to nTri a 
14 or rTri a 14 (ICC =-0.014 and -0.003, respectively; 
P> =0.05 in both cases). In addition, ELISA-inhibition 
assays (Fig. 5) reflected a similar inhibitory behaviour of 
both allergen forms, but uncovering a slightly lower 
potency of rTri a 14 (allergen concentration to reach 50% 
inhibition: (a) nTri a 14 in solid phase: 0.86 and 1.50 (ig/ 
mL for nTri a 14 and rTri a 14, respectively; (b) rTri a 14 in 
solid phase: 0.96 and 1.20(ig/mL for nTri a 14 and rTri a 
14, respectively). 
Basophil activation tests (BATs) supported the biologi-
cal activity of the natural and recombinant allergen (Table 
3). Two and one out of three patients with baker's asthma 
showed positive responses to nTri a 14 and rTri a 14, 
respectively. 
Table 3. Maximum basophil activation responses induced by a wheat salt 
soluble protein extract (WE), nTri a 14 and rTri a 14 in blood from 
patients with baker's asthma 
Subject no.' 
I 
II 
III 
C 
Time (years) 
without contact 
3 
5 
5 
% activated basophils (SI)+ 
WE nTri a 14 rTri a 14 
(1 ug/mL) (1 ug/mL) (0.1 ug/mL) 
49.2(259.2) 46.6(245.4) 34.7(183.0) 
28.4(25.1) 31.3(27.8) 0.2(0.2) 
28.5(150.0) 0.5(2.8) 0.8(4.5) 
0.9(1.6) 0.4(0.8) 1.0(1.7) 
Subjects I, II and III are patients with baker's asthma caused by wheat 
flour inhalation and subject C is an atopic patients without baker's 
asthma. 
tYears without contact with inhaled wheat flour. 
+Maximum activation values. SI> 5 was considered a positive response. 
SI, stimulation index. 
Both natural and recombinant Tri a 14 are resistant to 
simulated gastric and duodenal digestion 
The behaviour of recombinant Tri a 14 to proteolytic 
enzymes, compared with that of nTri a 14 and nPru p 3, 
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Fig. 6. Simulated gastric followed by duodenal digestion of natural (n) 
and recombinant (r) Tri a 14, and natural Pru p 3. Samples (5^g) were 
fractionated by SDS-PAGE after 120 min of simulated gastric digestion 
(SGF) or 2, 30, 60, or 120 min of a following simulated duodenal 
digestion (SDF). Time 0 represents control samples in SGF without 
pepsin, or SDF without trypsin and a-chymotrypsin. 
was checked in SGF followed by duodenal digestion fluid 
(SDF) (Fig. 6). All three purified allergens were mostly 
resistant to both SGF (120 min) and SDF (120 min after 
SGF treatment), thus indicating that both forms of Tri a 14 
(natural and recombinant) probably remain immunologi-
cally active during gastrointestinal digestion. 
Discussion 
In spite of the relevance of baker's asthma as occupational 
disease, no panel of molecular markers to diagnose this 
allergic disorder have been developed. The low sensitiza-
tion rates (as estimated by specific IgE) to most identified 
allergens associated with this disease, together with the 
limited number of patients studied in each case [9-13], 
and the reported variability in sensitization patterns [14], 
have probably retarded the development of such molecu-
lar panel. In contrast, specific IgE to co-5 gliadin has 
been proposed as a useful tool for diagnosis of wheat-
dependant exercise-induced anaphylaxis and wheat food 
allergy [31,32]. 
Tri a 14, an abundant LTP in wheat seeds, has been 
recently identified by in vitro and in vivo methods as a 
major allergen associated with baker's asthma in Spanish 
patients [16]. Additionally, it seems to be also relevant in 
wheat IgE-mediated food allergy in Italian subjects [17]. 
This background suggests that Tri a 14 could be a useful 
tool for diagnosis of wheat allergy, at least in the Medi-
terranean population. Accordingly, as a preliminary step, 
the cDNA coding for Tri a 14 was isolated and its 
recombinant form expressed in the yeast P. pastoris to 
produce high and homogeneous amounts of such a tool, 
and to allow its future manipulation by protein engineer-
ing. The produced rTri a 14 was isolated from supernatants 
of transformed yeast cultures, and its purity and corre-
spondence with the natural allergen confirmed by SDS-
PAGE and MALDI analysis, and N-terminal amino acid 
sequencing, that detected the presence of three additional 
residues (EAE) with respect to the natural form. These 
extra residues do not seem to impair the equivalence of 
both allergen versions, but could weakly decrease the 
IgE-binding capacity of the recombinant form, as dis-
cussed below. 
The use of the recombinant form of an allergen as a 
potential diagnostics tool, previously requires to ascertain 
the similarity of its biophysical and immunological prop-
erties to those of its natural counterpart. The almost 
identical CD spectra and heat denaturation profiles of nTri 
a 14 and rTri a 14 support their physicochemical equiva-
lence, as well as the proper expression of the recombinant 
protein. On the other hand, two lines of evidence point to 
the similar IgE-binding capacity of both Tri a 14 forms. 
Specific IgE determination uncovered equivalent qualita-
tive and quantitative responses (61% vs. 54% positive sera 
and mean values of 0.25 vs. 0.26 OD units for nTri a 14 
and rTri a 14, respectively), which render a statistically 
significant correlation (ICC = 0.882; P<0.001) between 
the levels of specific IgE to each allergen version in 
individual sera from patients with baker's asthma. Results 
of ELISA-inhibition assays reflected also a comparable 
behaviour against specific IgE of the natural and recom-
binant Tri a 14, but a slightly lower potency (^20%) of the 
latter form. Besides, more than 50% of the 26 individual 
sera analysed contain specific IgE to Tri a 14, confirming 
previous data [16] on its prevalence in Spanish adult 
subjects with baker's asthma. Additionally, the results of 
BATs indicate that both allergen forms are biologically 
active, although also suggesting a lower activity of rTri 
a 14. 
The experimental data presented here focus a second 
issue related to Tri a 14: the putative lower structural 
stability of this allergen than other members of the LTP 
panallergen family, such as maize Zea m 14, as well as its 
potential divergent three-dimensional (3D) structure [17, 
18]. nPru p 3, the major fruit peach allergen and proto-
typic member of the plant food LTP family involved in 
allergic reactions [18], was tested here as a reference 
model. Comparison of the CD and thermal denaturation 
spectra of natural Tri a 14 and Pru p 3 indicates that both 
LTP allergens showed a very similar secondary structure 
and probably 3D folding (confirmed by the experimental 
data previously reported [29, 30]), as well as thermal 
resistance. In fact, important changes in secondary struc-
ture were only detected over 90 °C, thus highlighting the 
high thermal stability of both wheat and peach allergens. 
Moreover, a strong resistance to simulated gastrointest-
inal digestion has been detected for Tri a 14, similar to that 
of Pru p 3, and in line with those found for other allergenic 
LTPs [18, 33, 34]. Resistance of wheat LTP to simulated 
gastric digestion using a different experimental protocol, 
as well as its Caco-2 cell line translocation capability, 
have been previously demonstrated [35]. Therefore, it does 
seem that the wheat LTP allergen displays neither lower 
structural stability nor divergent 3D structure as com-
pared with the Pra p 3 model. However, processing of 
wheat seeds or flour to produce derived foodstuffs could 
modify the Tri a 14 allergen and hardly affect both its 3D 
structure and IgE-binding properties [19]. In this line, 
different types of biochemical modifications have been 
described in barley LTP during the brewing process [36]. 
Finally, it should be mentioned that, in spite of the 
extensive evidence here presented supporting the physi-
cochemical and immunological similarity of nTri a 14 and 
rTri a 14, to test sera from large groups of baker's asthma 
patients from different geographical areas is necessary to 
further confirm the usefulness of rTri a 14 as a tool in 
baker's asthma diagnosis. 
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